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Peroxiredoxin 3 (PRX3), a typical 2-Cys peroxiredoxin located exclusively in the mitochondrial matrix, is
the principal peroxidase responsible for metabolizing mitochondrial hydrogen peroxide, a byproduct of
cellular respiration originating from the mitochondrial electron transport chain. Mitochondrial oxidants
are produced in excess in cancer cells due to oncogenic transformation and metabolic reorganization,
and signals through FOXM1 and other redox-responsive factors to support a hyper-proliferative state.
Over-expression of PRX3 in cancer cells has been shown to counteract oncogene-induced senescence and
support tumor cell growth and survival making PRX3 a credible therapeutic target. Using malignant
mesothelioma (MM) cells stably expressing shRNAs to PRX3 we show that decreased expression of PRX3
alters mitochondrial structure, function and cell cycle kinetics. As compared to control cells, knockdown
of PRX3 expression increased mitochondrial membrane potential, basal ATP production, oxygen con-
sumption and extracellular acidiﬁcation rates. shPRX3 MM cells failed to progress through the cell cycle
compared to wild type controls, with increased numbers of cells in G2/M phase. Diminished PRX3 ex-
pression also induced mitochondrial hyperfusion similar to the DRP1 inhibitor mdivi-1. Cell cycle pro-
gression and changes in mitochondrial networking were rescued by transient expression of either cat-
alase or mitochondrial-targeted catalase, indicating high levels of hydrogen peroxide contribute to
perturbations in mitochondrial structure and function in shPRX3 MM cells. Our results indicate that
PRX3 levels establish a redox set point that permits MM cells to thrive in response to increased levels of
mROS, and that perturbing the redox status governed by PRX3 impairs proliferation by altering cell cycle-
dependent dynamics between mitochondrial networking and energy metabolism.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Oxidative stress, deﬁned as the imbalance between the pro-
duction and the elimination of cellular oxidants by antioxidants,
contributes to cancer initiation, progression and survival [1].
Due to their ability to damage cellular macromolecules, reactive
oxygen species (ROS) must be dynamically regulated for normal
and cancer cells to maintain steady state levels below the cytotoxic
threshold [1]. In normal cells oncogenic stimuli, such as activated
Ras, increases the production of cellular oxidants, leading to oxi-
dative stress and ultimately inducing senescence [2]. Tumor cells
must adapt in order to evade this fate and therefore commonly
over-express antioxidant enzymes, such as superoxide dismutaseB.V. This is an open access article
eintz).
.2 (MnSOD, SOD2) and peroxiredoxin 3 (PRX3), which permits
escape from oncogene-induced senescence [3].
Mitochondria are dynamic cellular organelles responsible for
producing the majority of adenosine triphosphate (ATP), the pri-
mary energy source of the cell. Mitochondria are the primary
producers of cellular ROS, both as a byproduct of aerobic respira-
tion [4] and from other important mitochondrial sources [5]. The
inner mitochondrial membrane contains the electron transport
chain (ETC), which provides the driving force for ATP synthesis via
electron ﬂow, proton pumping, and the formation of an electro-
chemical gradient fueling ATP synthase (complex V). Electron
leakage, primarily at complexes I and III, leads to the incomplete
reduction of molecular oxygen which forms superoxide radical [6].
Superoxide is an unstable intermediate that is spontaneously or
enzymatically dismutated to hydrogen peroxide (H2O2), the pri-
mary oxidant implicated in redox signaling [7]. Under basal con-
ditions resident cytosolic and mitochondrial antioxidant enzymes
maintain proper redox status while changes in the rate of oxidantunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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pathways. Numerous signaling networks responsive to cellular
oxidants have been identiﬁed, and these inﬂuence survival, pro-
liferation and stress signaling pathways in normal and pathologi-
cal settings [8].
Peroxiredoxin 3 (PRX3) is a member of the typical 2-Cys per-
oxiredoxin family (PRX 1–4) and functions as the primary oxi-
doreductase in the mitochondria responsible for metabolizing
H2O2 [9] . PRX3 exists as a head to tail homodimer that utilizes a
peroxidatic cysteine that reacts with a molecule of H2O2, thereby
forming a sulfenic acid (–SOH) intermediate. After local unfolding
of the active site, the resolving cysteine located on the adjacent
monomer then forms a disulﬁde bond with the oxidized perox-
idatic cysteine [10]. Thioredoxin 2 (TRX2) reduces this disulﬁde
bond and thereby reactivates PRX3 [11]. A structural C-terminal
extension found in typical 2-cys peroxiredoxins slows disulﬁde
bond formation, allowing another molecule of H2O2 to further
oxidize the peroxidatic cysteine to sulﬁnic (–SO2H) acid [12]. Ty-
pically these additional oxidation events are irreversible and lead
to an inactive protein, but a system comprised of sulﬁredoxin and
ATP speciﬁcally regenerates active PRX3 [13,14]. This is a slow,
energy-dependent reaction that has been hypothesized to allow
transient and local increases in ROS levels to modulate redox-de-
pendent signaling pathways [12].
Increases in mitochondrial oxidant levels may lead to the ac-
tivation of stress signaling pathways and can cause cellular da-
mage when oxidant levels reach a cytotoxic threshold. In order to
escape oxidative stress, mitochondria have been shown to un-
dergo structural rearrangements during which damaged and
healthy mitochondria fuse, effectively reducing the number of
damaged mitochondrion and ameliorating oxidative stress [15]. In
addition to decreasing ROS, mitochondrial fusion has been shown
to support increased ATP output from mitochondria [16].
A unique form of mitochondria at the G1/S phase of the cell
cycle has been identiﬁed and described as an extensive hyperfused
network with higher ATP producing capacity [16]. During cell
cycle progression, mitochondrial fragmentation is required for
proper segregation of mitochondria to daughter cells during
mitosis [17,18]. Loss of dynamin-related protein 1 (DRP1), the
primary enzyme responsible for mitochondrial ﬁssion, leads to cell
cycle arrest at the G2/M phase. Furthermore, loss of DRP1 leads to
hyperfusion of mitochondrial networks and increased ATP levels
[19]. The redox status of the cell has also been shown to play a
fundamental role in cell cycle progression where transient in-
creases in ROS activate cell cycle signaling pathways [20]. These
ﬁndings provide evidence for a functional relationship between
mitochondrial structure and function and cell cycle progression.
In this report we identify PRX3 as an important regulator of
mitochondrial metabolism and structure in human malignant
mesothelioma cells. Changes in the basal redox status of mi-
tochondria through stable knockdown of PRX3 led to alterations in
energy production and changes to the mitochondrial network
through inactivation of DRP1 by dephosphorylation at Serine 616.
These alterations in mitochondrial structure induced a cell cycle
pause at the G2/M phase. Mitochondrial structural perturbations
in shPRX3 cells, as well as cell cycle abnormalities, were rescued
by expression of catalase or mito-catalase, both of which corrected
mitochondrial redox status back to control levels. Together these
results indicate that PRX3 establishes a mitochondrial redox set
point that supports proper integration of metabolic status,
mitochondrial structure and cell cycle dynamics.Results
Knockdown of PRX3 increases mitochondrial oxidant levels in HM
cells
Using human malignant mesothelioma cells (HM) as a model
for a ROS-driven tumor cell line [21] we sought to investigate the
phenotype associated with lowering expression of the mitochon-
drial oxidoreductase peroxiredoxin 3 (PRX3), the antioxidant en-
zyme responsible for metabolizing the majority of mitochondrial
peroxide [22]. HM cell lines stably expressing short hairpin RNA
against PRX3 were generated (HMshPRX3) and successful knock-
down was conﬁrmed by immunoblotting (Fig. 1A) and immuno-
ﬂuorescence microscopy (Fig. 1B). The relative mean ﬂuorescence
intensity (MFI) for anti-PRX3 signal was quantiﬁed from im-
munoﬂuorescence images and found to be approximately 6-fold
lower than HM cells (Fig. 1C). PRX3 is estimated to metabolize
approximately 90% of mitochondrial H2O2 [22] and therefore it
would be expected that reduced expression of PRX3 would alter
the redox status of the mitochondria. HM and HMshPRX3 cells
were loaded with MitoSOX Red, a ﬂuorescent indicator of general
oxidant levels in the mitochondrial matrix, and analyzed by ﬂow
cytometry. HMshPRX3 cells showed a 30% increase in MitoSOX
RED ﬂuorescence, thereby indicating an increase in the levels of
mitochondrial oxidants in these cells (Fig. 1D).Knockdown of PRX3 alters the metabolic proﬁle of HM cells
Among the many processes of mitochondria, including calcium
buffering [23], propagation of apoptotic signals [24] and produc-
tion of ROS [4], their primary role is to provide energy in the form
of adenosine triphosphate (ATP). The transport of electrons
through the electron transport chain (ETC) with oxygen as the ﬁ-
nal electron acceptor supports the pumping of hydrogen atoms
across the inner mitochondrial membrane, thereby producing the
electrochemical gradient that drives ATP production at complex V
(ATP synthase). We measured ATP levels in HMshPRX3 cells and
found them to be signiﬁcantly elevated above those of HM cells,
and both cell lines were responsive to the ATP synthase inhibitor
oligomycin (Fig. 2A). Mitochondrial membrane potential supports
the ﬂow of electrons through the ETC, and ATP levels ﬂuctuate
based on changes to mitochondrial membrane potential. Sup-
porting the evidence that HMshPRX3 cells have increased relative
ATP levels as compared to HM cells, they also have an increased
mitochondrial membrane potential compared to HM cells as
measured with the cell permeant positively charged ethyl ester
TMRE (Fig. 2B).
Using Seahorse extracellular ﬂux analysis we compared meta-
bolic features of HM and HMshPRX3 cells. Basal oxygen con-
sumption rates (OCR) and extracellular acidiﬁcation rates (ECAR)
were increased in HMshPRX3 cells compared to HM cells (Fig. 2C
and D). The observed increase in ATP levels, membrane potential
and oxygen consumption suggests increased mitochondrial me-
tabolism in HMshPRX3 cells. We could not directly measure this
change as HMshPRX3 cells failed to respond to ETC inhibitors to
reveal reproducible mitochondrial metabolism proﬁles using the
Seahorse Bioanalyzer (data not shown, see discussion). To control
for differences in mitochondrial mass, which would confound the
observed metabolic changes, mitochondrial mass was quantiﬁed
from ﬂuorescence images and found to be equal for both the
shPRX3 and HM control cell lines (Supplemental Fig. 1).
Fig. 1. Knockdown of PRX3 in MM cells increases mitochondrial oxidant levels. (A) Immunoblot showing PRX3 expression in HM and shPRX3 HM (HMshPRX3) cell lines.
Actin was used as a loading control. (B) Immunoﬂuorescent images of HM and HMshPRX3 cells stained with anti-PRX3 antibody (green) and DAPI (cyan) (scale bar¼10 mm).
(C) Quantiﬁcation of anti-PRX3 ﬂuorescence intensity (mean ﬂuorescence intensity, MFI) in HM and HMshPRX3 cells (nnnn po0.0001, n¼10 cells). (D) Flow cytometry
histograms of HM and HMshPRX3 cells stained with MitoSOX Red; ﬂuorescent intensity was collected in the FL2 channel. Percent cells included in the gate are indicated (red
line).
Fig. 2. HMshPRX3 cells have an altered metabolic phenotype. (A) ATP levels (A.U.¼arbitrary units) measured in HM and HMshPRX3 cells. 5 mM oligomycin (Oligo) reduces
ATP levels by blocking complex V activity (nnnn po0.0001, n¼5). (B) Mitochondrial membrane potential measured by TMRE ﬂuorescence in HM and HMshPRX3 cell lines.
1 mM CCCP uncouples mitochondrial membrane potential (nn po0.01, n¼5). (C) Basal extracellular acidiﬁcation rates (ECAR) of HM and HMshPRX3 cells measured with a
seahorse Bioanalyzer (nn po0.01, n¼5). (D) Basal oxygen consumption rates (OCR) of HM and HMshPRX3 cells (nn po0.001, n¼5).
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Fig. 3. HMshPRX3 cells exhibit hyperfused mitochondrial networks and altered cell cycle phenotype. (A) Fluorescent images of HM and HMshPRX3 cells transfected with
expression vectors for mito-dsRED and CFP-Actin. Scale bar¼10 mm. (B) Quantiﬁcation of mitochondrial networks (see Materials and methods section) in control (Ctrl),
mdivi-1 treated HM cells and HMshPRX3 cells (nn po0.01, nnn po0.001, n¼10 cells). (C) Immunoblot for phospho-DRP1 (Ser 616) and total DRP1 in HM (Ct), HMshPRX3 (sh)
and HM cells treated with 10 mM mdivi-1 for 24 h (D) representative cell cycle ﬂow cytometry histograms of HM and HMshPRX3 cells stained with propidium iodide.
(E) Percentage of cells in the G2/M cell cycle phase in the indicated cell lines (nn po0.01, n¼3).
B. Cunniff et al. / Redox Biology 3 (2014) 79–8782Knockdown of PRX3 induces mitochondrial fusion and cell cycle ar-
rest in G2/M
Mitochondrial structure is affected by and directly inﬂuences
numerous functional processes, including ATP production [16,19],
ROS production [25,26] and calcium buffering [27]. Given the
signiﬁcant metabolic differences between HMshPRX3 and HM
cells we investigated if there were differences in mitochondrial
networks. HM and HMshPRX3 cells were transfected with ﬂuor-
escent expression vectors to label mitochondria (mito-dsRED) and
the actin cytoskeleton (CFP-Actin). HM cells showed a fragmented
perinuclear mitochondrial network (Fig. 3A), reminiscent of other
tumor cell types in which mitochondrial ﬁssion supports tumor
cell migration and survival [28,29]. Conversely HMshPRX3 cells
showed a more elongated and ﬁlamentous mitochondrial network
that extended into the cell periphery (Fig. 3A). HMshPRX3 cells
were observed to be slightly larger than HM cells but no statisti-
cally signiﬁcant increases in cell mass were observed (data not
shown). Quantiﬁcation of mitochondrial networks showed that
HMshPRX3 cells exhibited a signiﬁcant increase in mitochondrial
length and branching, which could be recapitulated in HM cells by
incubation with the DRP1 ﬁssion inhibitor mdivi-1 (Fig. 3B).
DRP1 has two previously described phosphorylation sites that
differentially regulate its activity [30,31]. Phosphorylation at serine
616 of DRP1 leads to increased activity and mitochondrial ﬁssion.
HMshPRX3 cells showed decreased phosphorylation of DRP1 at
serine 616 similar to that of HM cells treated with the DRP1 in-
hibitor mdivi-1 (Fig. 3C), and this change correlated with increasedmitochondrial networking observed by ﬂuorescence imaging
(Fig. 3A and B).
Mitochondria undergo ﬁssion at late metaphase prior to mi-
tosis in a DRP1-dependent manner, which ensures equal dis-
tribution of mitochondria to daughter cells [32]. Given the mi-
tochondrial structural aberrations and reduced DRP1 phosphor-
ylation at serine 616 in HMshPRX3 cells, we investigated cell cycle
progression in HMshPRX3 cells compared to HM controls. A re-
presentative cell cycle histogram as analyzed by ﬂow cytometry
after propidium iodide staining indicated HMshPRX3 cells have an
increased proportion of cells in the G2/M cell cycle phase com-
pared to HM cells (Fig. 3D). Comparison of the percentage of cells
in G2/M to G1 and S phases of the cell cycle showed that
HMshPRX3 cells had signiﬁcantly more cells in the G2/M phase
compared to HM cells (Fig. 3E). An increase in cells in the G2/M
cell cycle phase was also seen in HM cells treated with the DRP1
inhibitor mdivi-1 (Fig. 3E). These data indicate that mitochondrial
fusion in HMshPRX3 cells contributes to an accumulation of cells
at the G2/M phase of the cell cycle.
Catalase expression rescues mitochondrial structural aberrations and
cell cycle abnormalities in HMshPRX3 cells
Increased oxidant levels disrupt normal cell cycle progression
and have been shown to induce mitochondrial fusion as a means
of escaping increased oxidative stress [33]. To determine whether
increased oxidant levels contribute to the altered mitochondrial
structure and abnormal cell cycle proﬁles observed in HMshPRX3
Fig. 4. Catalase expression restores HMshPRX3 mitochondrial structural aberrations and cell cycle abnormalities. (A) Mitochondrial oxidant levels in cells transfected with
indicated expression vectors. MitoSOX Red oxidation was measured by ﬂow cytometry 24 h after cell transfection (n po0.05, n¼2). (B) Mitochondria of HM cells and shPRX3
cells transiently transfected with control vector (pZeo), catalase (CAT), or mito-catalase (mCAT) and mito-dsRED were imaged by ﬂuorescent microscopy 24 h after trans-
fection (scale bar ¼ 10 mm). (C) Quantiﬁcation of mitochondrial networks of cells transfected with the indicated expression vectors as in A (n po0.05, n.s.¼not signiﬁcant,
n¼10 cells). (D) Percentage of cells in the G2/M cell cycle phase as measured by ﬂow cytometry in cells transfected with indicated expression vectors as in A (n po0.05,
n¼3).
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tochondrial targeted catalase (mCAT) in HMshPRX3 cells and ex-
amined mitochondrial oxidant levels, mitochondrial structure and
cell cycle progression. Expression of CAT or mCAT in HMshPRX3
cells signiﬁcantly lowered the level of mitochondrial oxidants to
the levels comparable to HM cells as measured by ﬂow cytometry
after staining with MitoSOX Red (Fig. 4A). Analysis of ﬂuorescent
images of cells expressing mito-dsRED to label mitochondria
showed that HMshPRX3 cells expressing CAT or mCAT showed a
more fragmented mitochondrial network than HMshPRX3 cells
expressing control vector (Fig. 2B). Quantiﬁcation of mitochondrial
length and branching conﬁrmed this observation as HMshPRX3/
CAT and HMshPRX3/mCAT cells had mitochondrial networks si-
milar to HM cells, while HMshPRX3 cells continued to harbor
fused mitochondrial networks (Fig. 4C).We next investigated if the lower mitochondrial redox status
and fragmented mitochondrial network were sufﬁcient to rescue
the G2/M cell cycle block observed in HMshPRX3 cells.
HMshPRX3/CAT and HMshPRX3/mCAT cell cycle proﬁles were
determined by ﬂow cytometry after propidium iodide staining,
and showed a reversal of the G2/M cell cycle block observed in
HMshPRX3 cells (Fig. 4D).Discussion
Our data support the hypothesis that PRX3 establishes a redox
set point required for proper mitochondrial structure and cell
cycle progression. Increases in mitochondrial oxidants and chan-
ges in antioxidant expression have been implicated in a wide
range of pathological states where altered redox balance
B. Cunniff et al. / Redox Biology 3 (2014) 79–8784contributes to the onset and progression of the disease [34].
Speciﬁcally, mitochondrial oxidants are increased in cancer, in-
cluding KRAS driven lung tumors, and support proliferation and
metastasis of tumor cells [35]. Changes in the redox landscape of
tumor cells activates stress response programs that would typi-
cally lead to senescence unless excessive oxidants are counter-
balanced through metabolic reorganization, as for example by up-
regulation of antioxidant enzymes [36]. The redox responsive
oncogenic transcription factor FOXM1 is expressed in every solid
tumor studied to date and is required for escape from cytotoxic
oxidant levels by increasing the expression mitochondrial anti-
oxidant enzymes SOD2 (MnSOD) and PRX3 [3]. This adaptation is
required for oncogenic transformation and has been shown to be a
unique metabolic target as it is largely independent of any speciﬁc
oncogene or tumor suppressor alterations [36].
Increased expression of peroxiredoxins, including PRX3, in tu-
mor cells counterbalances excessive cellular oxidants and pro-
motes a redox-dependent pro-proliferative state [3]. This pro-
proliferative state requires proper cell cycle progression, which is
intimately linked to cellular redox status [37,38], with the earliest
reports from the 1930s that indicated variability in protein thiol
status during different cell cycle phases [39]. Extensive studies
since then have shown ﬂuctuations in antioxidant expression le-
vels, GSH:GSSG ratios and oxidant levels during different cell cycle
phases [40]. The mitochondria, being a primary intracellular
source of oxidants, have also been implicated as an important
source of oxidants that govern cell cycle progression [41]. The
activity of the mitochondrial superoxide scavenger MnSOD has
been shown to modulate cell cycle entry, exit and progression [42],
while we have reported signiﬁcant increases in mitochondrial
oxidants during progression from G1 to M phase [43].
The data reported here support a role for PRX3 in the regula-
tion of cell cycle dynamics (Figs. 3 and 4), while others have shown
the role of other PRX family members in this process.
H2O2-dependent cell cycle arrest leads to the hyperoxidation of
PRX2, inducing the formation of higher molecular weight oligo-
mers, which must be reduced prior to cell cycle reentry [44].
Knockdown of PRX2 in glioblastoma cells leads to arrest in G2/M
with a concomitant increase in intracellular and extracellular
oxidants [45]. Inactivation of PRX1 through phosphorylation by
CDK1 (Cdc2) stimulates transient, localized H2O2 levels hypothe-
sized to be required for inactivation of the protein tyrosine phos-
phatase Cdc25C and the complete activation of CDK1 at mitosis
[46]. Using a novel bioinformatics approach, Conour et al. [47]
proposed that the majority of redox-responsive cell cycle proteins
are involved in regulating transition through G2/M.
We show here that knockdown of PRX3 using targeted shRNAs
in malignant mesothelioma cells (HMshPRX3) led to an increased
mitochondrial oxidation state that was reversible through the
over-expression of catalase or mito-catalase (Fig. 4). Mitochondria
dynamically alter their structure and distribution in response to
intracellular signals including Ca2þ levels, energy needs and
stress. Mitochondrial structural rearrangements are coupled to
functional aspects of mitochondrial signaling and metabolism [48].
Our data indicate that mitochondrial redox status inﬂuences me-
tabolic features of mitochondria as HMshPRX3 cells exhibit in-
creased mitochondrial membrane potential and ATP levels (Fig. 2).
This is in agreement with other studies that show reversible cy-
steine modiﬁcations to mitochondrial ETC proteins regulate their
activity and overall metabolic state [49]. The requirement of mi-
tochondrial metabolic demands to be responsive to oxidative
stress is supported by the general ﬁnding that ATP levels and
mitochondrial ROS exhibit an inverse relationship.
Using Seahorse extracellular ﬂux analysis we show that
HMshPRX3 cells have increased oxygen consumption rates (OCR)
and extracellular acidiﬁcation rates (ECAR) as compared to vectorWT controls (Fig. 2). HM tumor cells have a reduced mitochondrial
reserve capacity and a higher demand for mitochondrially-derived
ATP as compared to immortalized non-tumorigenic mesothelial
cells, while having similar ECAR proﬁles (manuscript in revision).
We were unable to conﬁrm the mitochondrial reserve capacity of
HMshPRX3 cells or their respective demand for mitochondrial ATP
as compared to WT controls because after addition of oligomycin
OCR rates dissipated and maximal respiration could not be sti-
mulated with the addition of CCCP (data not shown). These results
may indicate that the structural and metabolic rearrangements to
the mitochondria seen in HMshPRX3 cells reorganizes their me-
tabolic demand to be more reliant on mitochondrial ATP.
HMshPRX3 cells also had an increased ECAR compared to WT
controls, suggesting knockdown of PRX3 increases glycolysis
(Fig. 2). Changes in cellular oxidants such as have been shown to
regulate glycolytic pathways; speciﬁcally increasing ROS stimu-
lates glycolysis, while in contrast overexpression of superoxide
dismutase (SOD) reduced glycolysis independent of hypoxia in
hepatocytes [50]. MM cells are more sensitive to changes in oxi-
dant levels as compared to immortalized non-tumorigenic and
primary mesothelial cells, and have distinctive metabolic demands
(manuscript in revision). Therefore further investigation will be
needed to understand the role of mitochondrial H2O2 in the reg-
ulation of glycolytic pathways, particularly in the survival and
proliferation of rapidly dividing cancer cells.
Mitochondrial ﬁssion is required prior to cytokinesis to ensure
proper distribution to daughter cells, whereas mitochondrial hy-
perfusion supports increased ATP levels and cyclin E expression
required for G1-S progression. Increased mitochondrial stress has
been shown to induce fusion of organelles and the pro-fusion
regulator mitofusin-2 (MFN2) is redox-regulated through re-
versible cysteine oxidation that promotes mitochondrial fusion
[51]. Analysis of mitochondrial structure in HMshPRX3 cells
showed an increase in mitochondrial networking as compared to
wild type controls (Fig. 3). Although we did not investigate the
activity or oxidation state of MFN2 in these cells we did identify
post-translational changes in the primary ﬁssion molecule DRP1.
Phosphorylation of DRP1 at serine 616 promotes mitochondrial
ﬁssion, and we observed a signiﬁcant reduction in phosphoryla-
tion levels of serine 616 of DRP1 in HMshPRX3 cells (Fig. 3). This
loss in phosphorylation was also seen in wild type cells treated
with the DRP1 inhibitor mdivi-1 that also promoted mitochondrial
networking (Fig. 3).
Mitchel et al. have recently reported that endoplasmic re-
ticulum stress in Akita beta cells with mutations to the B insulin
chain (Akita þ/Ins2) have increased mitochondrial oxidative stress
and concomitant mitochondrial network fragmentation [52]. Al-
though these and other studies [25,26] indicate mitochondrial
oxidative stress is associated with mitochondrial fragmentation it
is difﬁcult to compare results across cells lines. Basal redox status,
metabolic requirements and different genetic signatures no doubt
inﬂuence mitochondrial stress responses. Other groups have
identiﬁed hyperfused mitochondrial networks during autophagy
[15], a process that is stimulated by mitochondrial-derived oxi-
dants [53]. These latter results indicate, as for other cellular stress
responses, that the length and duration of oxidant signaling in-
ﬂuence mitochondrial responses. A better understanding of the
molecular pathways that integrate speciﬁc redox modiﬁcations
with diverse structural and functional processes (e.g. mitochon-
drial ﬁssion–fusion cycles and metabolism) will be required to
clarify these apparently contradictory ﬁndings.
Based on our results we propose a model in which increased
mitochondrial oxidative stress caused by knockdown of PRX3 in-
duces mitochondrial hyperfusion through the inactivation of DRP1.
The altered redox status and increased mitochondrial networking
impairs proper cell cycle progression, perhaps by prolonging
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catalase rescued the phenotypic effects caused by diminished ex-
pression of PRX3, implying that increased levels of H2O2 were
responsible for the phenotypic effects of knocking down PRX3. We
suggest that PRX3 establishes a mitochondrial redox set point
required for proper mitochondrial structure, function and cell cy-
cle progression. Future work will be needed to fully understand
the link between mitochondrial redox status, mitochondrial
structure, energy metabolism and cell cycle progression, and how
these processes are corrupted during neoplastic transformation to
promote tumorigenesis.Materials and methods
Cell lines and cell culture
Human malignant mesothelioma cells (HM) were used in this
study [54]. Cells were maintained in DMEM-F12 with hydro-
cortisone, insulin, transferrin, and selenite with 10% fetal bovine
serum (FBS; GIBCO, Grand Island, NY).
Generation of stable Ctrl and shPRX3 cell lines
PRX3 and PLKO.1 lentiviral shRNAs were purchased from Sigma
and packaged following the manufacturers protocol (Sigma).
Stable shPRX3 and PLKO.1 (HM) cell lines were established by
seeding 35 mm tissue culture dishes with 1.25105 HM cells and
allowed to adhere overnight. The next day 150 mL of medium
containing shPRX3 lentiviral particles or shCtrl particles were
added to cells for 18 h. The cells were washed and incubated with
complete media to remove viral particles. Following 2 days, cul-
ture media was replaced with complete media containing mg/mL–
2 mg/mL puromycin and subsequently changed every 2 days until
control non-transduced cells were completely non-viable.
Cell cycle analysis
To determine cell cycle proﬁles cells were washed 1 with
PBS, trypsinized, and resuspended in 1 PBS. Cells were ﬁxed by
adding cold 100% EtOH drop wise while vortexing to a ﬁnal con-
centration of 80% EtOH. After incubation for 30 min at 4 °C, EtOH
was removed by centrifugation and cells were resuspended in a
working stock of propidium iodide (PI) containing RNase and 1%
fetal calf serum. Cell cycle proﬁles were determined by ﬂow
cytometry.
Transient transfections
Cells were plated into 35 mm dishes and transfected the fol-
lowing day with expression vectors for pZeo (control), catalase, or
mito-catalase using Lipofectamine 2000 (Invitrogen) following the
manufacture's instructions. For mitochondrial morphological as-
sessment and transfection efﬁciency mito-dsRED was included in
the transfection. Cells were used 24 h after transfection for in-
dicated experiments.
Reagents and inhibitors
Mdivi-1 was purchased from Enzo Life Sciences (Farmingdale,
NY) and tetramethylrhodamine ethyl ester (TMRE) was purchased
from Invitrogen. Oligomycin A and carbonyl cyanide m-chlor-
ophenyl hydrazine (CCCP) were purchased from Sigma (St. Louis,
MO). All compounds were re-suspended in molecular grade sterile
dimethyl sulfoxide (DMSO).Immunoblotting
Cell lysates were prepared by washing cells 1 with PBS and
scraping in NP-40 lysis buffer. After centrifugation at 14,000 RPM
protein concentrations were determined using Bradford assays
(Bio-Rad, Hercules, CA). Lysates (10–15 mg protein/well) were
resolved by reducing and denaturing polyacrylamide gel electro-
phoresis (SDS-PAGE) and prepared for immunoblotting as pre-
viously described [23]. Blots were blocked with 5% non-fat milk for
1 h. and incubated at 4 °C overnight with rabbit anti-PRX3 poly-
clonal antibody (Ab Frontier, Seoul, Korea) at a 1:2000 dilution,
anti-pDRP1 (Serine 616, Cell Signaling) at a 1:500 dilution, or anti-
DRP1 (Cell Signaling) at a 1:1000 dilution in blocking buffer.
Membranes were washed the following day 5 for 5 min with
1 Tris-buffered saline containing 0.2% Tween-20 (TBST). After
washing, protein bands were visualized with the Western Light-
ning chemiluminescent detection system (PerkinElmer, Waltham,
MA) using secondary antibodies coupled to horse radish perox-
idase. Blots were stripped and re-probed with a mouse anti-actin
antibody (Millipore, Billerica, MA) to verify equal protein loading.
MitoSOX Red ﬂow cytometry
Cells were loaded with 5 mMMitoSOX Red (Invitrogen) in tissue
culture medium for 30 min. Cells were washed with Hanks buf-
fered salt solution with calcium and magnesium (HBSS), collected
by brief trypsinization, centrifuged, and washed twice in HBSS.
Cell pellets were re-suspended in 1% bovine serum albumin (BSA)
in HBSS, and approximately 10,000 events were collected by ﬂow
cytometry. To measure oxidized MitoSOX Red, cells were excited at
488 nm and emission was collected in the FL2 channel.
ATP assay
ATP levels were determined using the ATPlite assay kit from
PerkinElmer (Waltham, MA). 2500 cells per well were plated into
96-well plates and treated the following day with indicated
compounds for 1 h. After treatment, cells were washed 1 with
PBS and 50 mL of PBS was added back to each well. 25 mL of cell
lysis solution was added to each well and the plate was shaken on
an orbital shaker for 5 min 25 mL of ATP substrate was added to
each well and mixed. 75 mL from each well was transferred to a
white 96-well plate. The plate was subsequently dark adapted for
10 min and luminescence was read in a Synergy HT plate reader
(BioTek, Winooski, VT).
Measurement of mitochondrial morphology
HM and HMshPRX3 cells were transfected with plasmids en-
coding Mito-dsRED and Cyan-LifeAct, as previously described [43],
to visualize mitochondria and actin cytoskeleton by ﬂuorescence
microscopy, respectively. Images were collected on a Nikon Ti-E
inverted microscope using the TRITC and CFP ﬁlter sets at appro-
priate exposure times using a 60 objective. Images of mi-
tochondria were subjected to top-hat ﬁltering as previously de-
scribed [55] using ImageJ software (NIH). The area and perimeter
of mitochondrial particles were determined and used to calculate a
mitochondrial form factor (FF), a measure of mitochondrial length
and branching, using the following formula: FF¼perimeter2
/4π area. Data are expressed as percent mitochondrial networks
compared to control cells.
Measurement of mitochondrial membrane potential
Cells were plates in 96-well plates at a density of 2500 cells per
well and treated the following day with indicated compounds for
B. Cunniff et al. / Redox Biology 3 (2014) 79–87861 h. 10 mM carbonyl cyanide m-chlorophenyl hydrazone (CCCP)
was added to speciﬁc wells and incubated for 10 min. The culture
media was removed and cells were incubated with 250 nM tet-
ramethylrhodamine, ethyl ester (TMRE). The plate was incubated
for 10 min. The cells were washed 1 with PBS and each well was
re-suspended in 100 mL PBSþ0.2% BSA and ﬂuorescence (ex
530 nm/em 590 nm) was read in a plate reader, as described
above.
Oxygen consumption rates (OCR) and extracellular acidiﬁcation rates
(ECAR)
Cells were plated in 24-well XF24 cell culture microplates at a
density of 40,000 cells per well. The following day cells were
washed 1 with XF cell culture media and 560 mL was added back
to each well. Cells were allowed to equilibrate in a CO2 in-
dependent incubator for 1 h. Basal OCR and ECAR were de-
termined using an XF24 Seahorse Bioanalyzer (Seahorse
Bioscience, North Billerica, MA). Oxygen and proton concentra-
tions were measured 3 over a 17 min period and graphed as the
mean of 5 replicates.
Statistical analysis
Data are presented as 7SEM. Statistical signiﬁcance was de-
termined using 1-way ANOVA with a Tukey's post-hoc test or the
students t test comparing control to experimental conditions for
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